Home›Stock Screener›Indegene

Indegene Share Price Today | Stock Price & Indegene Share Screener

INDGN Healthcare Technology
Live Share Price NSE
₹598.45
▲ 4.95 (0.83%)
2026-10-05 00:00:00
Live Share Price BSE
₹598.35
▲ 4.35 (0.73%)
2026-10-05 00:00:00

As of October 5, 2026, the live Indegene share price (NSE: INDGN) is ₹598.45 on NSE and ₹598.35 on BSE, up 0.83% from the previous close, with shares trading between ₹588.00 and ₹605.50 in today's trading session, and a 52-week range of ₹423.50–₹613.30. Check Indegene 52-week for the annual price range and momentum. Use the Indegene stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Indegene opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹1,092 and net income of ₹116, with EBITDA of ₹203, an operating margin of 16.0% and a profit margin of 10.6%.

Indegene Market Cap ₹14,581.35 Cr.
INDGN P/E Ratio (TTM) 36.84
Indegene P/B Ratio 4.71
EPS (TTM) ₹16.72
Dividend Yield 0.37%
Debt to Equity 0.04
INDGN 52 Week High ₹613.30
Indegene 52 Week Low ₹423.50
Operating Margin 16.00%
Profit Margin 10.62%
INDGN Revenue (TTM) ₹1,092.00
EBITDA ₹203.00
Net Income ₹116.00
Total Assets ₹4,620.00
Total Equity ₹3,139.00

Indegene Share Price Chart

Track the current stock price of Indegene with an interactive chart. Analyse INDGN share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Indegene stock quote in one place.

The quote of ₹598.45 sits between the 52-week low of ₹423.50 and the 52-week high of ₹613.30, and the latest session moved 0.83% from the previous close.

Indegene Company Profile - Fundamental Screener

Screen Indegene company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for INDGN shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Healthcare Technology industry, with Manish Gupta listed as chairperson or CEO, and it trades under ISIN INE065X01017.

Business Overview

Indegene Limited is a global provider of digital-led commercialization services for the life sciences industry. The company offers solutions in analytics, technology, and commercial, medical, regulatory, and safety services to biopharmaceutical, emerging biotech, and medical devices companies. Indegene operates through four main segments: Enterprise Commercial Solutions, Omnichannel Activation, Enterprise Medical...more

Company Details

Classification

Sector Healthcare
Industry Healthcare Technology
Sub-Sector Healthcare Technology
Segment E

Identifiers and Leadership

Chairperson/CEO Manish Gupta
ISIN INE065X01017

Indegene Balance Sheet Screener

Screen INDGN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹4,620, up from ₹3,326 in 2025.

Latest statistics put total assets at ₹4,620 and shareholder funds at ₹3,139, with a leverage ratio of 0.04.

Item 2026 2025 2024 2023 2022 2021 2020 2019

Assets

Total Assets 4,620 3,326 2,546 2,204 1,354 596 600 329
Current Assets 2,618 2,530 1,791 1,449 1,130 459 418 185
Fixed Assets 1,812 678 646 664 138 86 119 104

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0
Current Liabilities 395 146 506 651 149 64 369 18
Non-Current Liabilities 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 3,139 2,616 1,429 1,064 764 333 -16 152
Share Capital 48 48 44 44 0 0 0 79
Reserves & Surplus 3,090 2,567 1,385 1,020 764 324 -105 73

Indegene Income Statement Screener - Profit & Revenue Analysis

Screen Indegene income statement and profit fundamentals. Analyze INDGN quarterly results. Indegene reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Jun, revenue was ₹1,092 and net profit was ₹116, equal to earnings per unit of ₹4.84, at an operating margin of 16%.

In that period expenses were ₹889, interest cost ₹6 and tax ₹37. The next period listed, 2026-Mar, shows revenue of ₹1,014 and net profit of ₹80.

Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar 2022-Jun

Revenue and Expenses

Revenue 1,092 1,014 962 824 783 781 758 708 699 699 687 647 636 645 540
Expenses 889 860 783 664 606 608 589 561 548 534 525 515 511 535 413

Operating Costs and Margins

EBITDA 203 154 179 160 177 173 170 148 151 164 162 133 125 111 127
Operating Profit % 16.00% 14.00% 17.00% 17.00% 20.00% 20.00% 18.00% 18.00% 19.00% 21.00% 22.00% 19.00% 16.00% 15.00% 21.00%
Depreciation 44 42 40 23 22 21 20 19 20 19 18 20 20 20 10
Interest 6 7 5 4 4 3 3 4 12 12 12 12 13 12 2

Profit and Earnings

Profit Before Tax 153 105 135 133 152 149 146 124 120 134 132 101 93 79 115
Tax 37 25 32 31 36 32 37 32 32 39 34 26 24 30 29
Net Profit 116 80 103 102 116 118 110 92 88 95 99 75 68 49 86
EPS 4.84 3.32 4.29 4.26 4.86 4.91 4.59 3.84 3.79 4.27 4.45 3.38 3.09 2.20 3.88

Indegene Cash Flow Screener - Liquidity Fundamentals

Screen INDGN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹651, and net cash flow was an inflow of ₹60.

Over the same period, investing activities used ₹508 and financing activities used ₹83.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March

Cash from Operations and Investing

Operating Activities 651 442 508 130 297 172 22 65
Investing Activities -508 -677 -327 -896 -158 -81 -16 -18

Financing and Net Cash

Financing Activities -83 288 -66 333 234 -132 136 -21
Net Cash Flow 60 52 115 -433 373 -41 143 25

Indegene Shareholding Pattern Screener

See Indegene shareholding pattern with promoter, FII, and DII holdings. Check Indegene promoter holding and ownership changes for INDGN on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 0.00%, foreign institutions 10.27%, domestic institutions 8.30% and the public 12.57%, spread across 142,119 shareholders.

The shareholder count was 142,119 in 2026-Mar, compared with 138,533 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Apr

Promoter Holding

Promoter Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Institutional Investors

FII Holding 10.27% 9.91% 5.24% 10.05% 11.30% 11.48% 3.56% 0.00%
DII Holding 8.30% 8.74% 4.96% 7.20% 6.96% 8.07% 5.33% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 12.57% 12.49% 11.34% 13.51% 13.28% 12.45% 11.38% 0.00%
Other Holding 68.87% 68.86% 78.45% 69.24% 68.46% 68.00% 79.73% 100.00%
Shareholder Count 142,119 138,533 144,708 151,997 151,809 147,182 443,785 82

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Indegene. Indegene dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹2.25 per unit for 2026-March, a yield of 0.37%, compared with ₹2.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹2.25, ₹2.00 and ₹0.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹2.25 0.37%
2025-March ₹2.00 0.46%
2024-March ₹0.00 0.00%
2023-March ₹0.00 0.00%
2022-March ₹0.00 0.00%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Indegene Stock Index Membership - Nifty & Sensex

See which indices include Indegene stock. Check INDGN index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 11 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX BSEIPO, BSE INDEX SMLCAP.

Complete Index List

BSE 1000
BSE INDEX BSE HC
BSE INDEX BSEIPO
BSE INDEX SMLCAP
NIFTY 500
NIFTY IPO
NIFTY MIDSML 400
NIFTY SMLCAP 250
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 MULTICAP

Indegene Market Events Screener - Corporate Actions

Get Indegene corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Indegene stock events that may affect INDGN share price, along with derivatives, futures and options activity and sector gainers.

14 corporate actions are listed, the most recent entry being Annual General Meeting dated August 13, 2026, with a record date of August 13, 2026.

It is followed by Dividend dated July 31, 2026 and Quarterly Result Announcement dated July 30, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-08-13 2026-08-13 Annual General Meeting NA 11.47%
2026-07-31 2026-07-31 Dividend ₹ 2.25 /share 2.95%
2026-07-30 2026-07-30 Quarterly Result Announcement NA 5.58%
2026-04-29 2026-04-29 Quarterly Result Announcement NA 3.54%
2026-01-29 2026-01-29 Quarterly Result Announcement NA -1.13%
2025-10-30 2025-10-30 Quarterly Result Announcement NA -1.67%
2025-07-31 2025-07-31 Quarterly Result Announcement NA -2.22%
2025-06-26 2025-06-26 Annual General Meeting NA -4.70%
2025-06-13 2025-06-13 Dividend ₹ 2.00 /share 5.49%
2025-04-28 2025-04-28 Quarterly Result Announcement NA -0.50%
2025-01-30 2025-01-30 Quarterly Result Announcement NA -6.18%
2024-10-28 2024-10-28 Quarterly Result Announcement NA 3.40%
2024-09-06 2024-09-06 Annual General Meeting NA 9.73%
2022-11-17 2022-11-17 Change Of Name NA -

Indegene Competitors Screener - Peer Stocks Comparison

Screen INDGN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 9 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Syngene International 14,823 68.69 3,809 2.56% 317 34.28
Indegene 14,581 36.84 3,583 21.58% 401 60.33
Suven Life Sciences 9,176 -25.81 21 19.32% -276 40.10
Vimta Labs 2,642 35.09 322 0.22% 41 40.61
Bilcare 237 -37.75 764 -5.33% -17 57.24
TAKE 207 16.89 61 497.06% 4 32.52
Jeevan Scientific Technology 163 30.25 62 29.56% 2 57.03
Adeshwar Meditex 24 33.09 56 -33.21% 1 21.12
Vanta Bioscience 15 136.87 2 -13.33% 0 49.20

Indegene Company Announcements - News & Reports Screener

Screen INDGN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 5, 2026.

The next most recent announcements are dated September 30, 2026 and September 10, 2026.

Date Update Actions
2026-10-05 Closure of Trading Window -
2026-09-30 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-09-10 Announcement under Regulation 30 (LODR)-Restructuring -
2026-09-08 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-08-31 Announcement Under Regulation 30 (LODR) - Update On Material Litigation -
2026-08-19 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-08-19 Announcement Under Regulation 30 (LODR) - Update On Material Litigation -
2026-08-17 Transcript Of The 28Th Annual General Meeting Held On August 13 2026 -
2026-08-17 Announcement under Regulation 30 (LODR)-Change in Directorate -
2026-08-17 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-08-14 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-08-13 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-12 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-08-12 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-08-10 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-08-10 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-08-06 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-08-01 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-31 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-07-30 Announcement under Regulation 30 (LODR)-Investor Presentation -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹598.45, within a 52-week range of ₹423.50 to ₹613.30. The P/E ratio is 36.84 and the P/B ratio is 4.71, with earnings per unit of ₹16.72. Market capitalisation stands at ₹14,581.35 Cr and the dividend yield is 0.37%. The company operates in the Healthcare sector, in the Healthcare Technology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 8 balance sheet periods, 15 income statement periods, 8 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.